Health
Patients with newly diagnosed atrial fibrillation benefit from early rhythm control therapy – News-Medical.Net
Patients with newly diagnosed atrial fibrillation benefit from early rhythm control therapy, according to results of the EAST-AFNET 4 trial presented in a Hot Line session today at ESC Congress 2020.
Patients with newly diagnosed atrial fibrillation benefit from early rhythm control therapy, according to results of the EAST-AFNET 4 trial presented in a Hot Line session today at ESC Congress 2020.
Rhythm control therapy is typically delayed unless patients have persistent symptoms on otherwise effective rate control. The EAST-AFNET 4 trial investigated whether rhythm control therapy – with antiarrhythmic drugs or ablation – delivered soon after diagnosis improves outcomes.
The risk of sever…
-
Noosa News20 hours agoHow Lily Steele-Park took her rapist to court and won
-
Noosa News24 hours agoStar’s Brisbane casino has been in the headlines for months: What’s the latest?
-
Noosa News21 hours agoE-biker charged with riding dangerously, assaulting cop
-
Business23 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025